Paul J. Hastings, CEO of Nkarta, Inc. ($NKTX), made two open market sales of company shares over the past year, totaling about $57,119. His most recent sale occurred on January 15, 2026. These sales rank him 10,255th among 11,678 individual insiders in our database by total value sold, well below the average of $8.6 million across 6.4 transactions per insider. Hastings made no open market purchases in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 15, 2026 | Nkarta, Inc. | $NKTX | HASTINGS PAUL J | Chief Executive Officer | S | Common Stock | 26046 | $2.07 | 390,023.0000 | 74,024,543 | 6.26% | 0.04% |
| Jan. 6, 2026 | Nkarta, Inc. | $NKTX | HASTINGS PAUL J | Chief Executive Officer | A | Common Stock | 94000 | $0.00 | 416,069.0000 | 74,024,543 | 29.19% | 0.13% |
| Jan. 6, 2026 | Nkarta, Inc. | $NKTX | HASTINGS PAUL J | Chief Executive Officer | A | Stock Option (right to buy) | 562000 | $0.00 | 562,000.0000 | 74,024,543 | 9999.99% | 0.76% |
| June 18, 2025 | Nkarta, Inc. | $NKTX | HASTINGS PAUL J | Chief Executive Officer | S | Common Stock | 1790 | $1.79 | 320,069.0000 | 67,865,323 | 0.56% | 0.00% |
| June 16, 2025 | enGene Holdings Inc. | $ENGN | HASTINGS PAUL J | Not found | A | Stock Option (Right to Buy) | 22500 | $0.00 | 22,500.0000 | 0 | 9999.99% | 0.00% |
| June 5, 2025 | Nkarta, Inc. | $NKTX | HASTINGS PAUL J | Chief Executive Officer | A | Stock Option (right to buy) | 377000 | $0.00 | 377,000.0000 | 67,865,323 | 9999.99% | 0.56% |
| Jan. 15, 2025 | Nkarta, Inc. | $NKTX | HASTINGS PAUL J | Chief Executive Officer | S | Common Stock | 17378 | $2.20 | 319,859.0000 | 67,865,323 | 5.15% | 0.03% |
| Jan. 3, 2025 | Nkarta, Inc. | $NKTX | HASTINGS PAUL J | Chief Executive Officer | A | Stock Option (right to buy) | 565500 | $0.00 | 565,500.0000 | 67,865,323 | 9999.99% | 0.83% |
| Jan. 3, 2025 | Nkarta, Inc. | $NKTX | HASTINGS PAUL J | Chief Executive Officer | A | Common Stock | 94500 | $0.00 | 337,237.0000 | 67,865,323 | 38.93% | 0.14% |
| June 18, 2024 | Nkarta, Inc. | $NKTX | HASTINGS PAUL J | Chief Executive Officer | S | Common Stock | 1770 | $5.60 | 240,737.0000 | 49,014,300 | 0.73% | 0.00% |
| June 15, 2024 | enGene Holdings Inc. | $ENGN | HASTINGS PAUL J | Not found | A | Stock Option (Right to Buy) | 40000 | $0.00 | 40,000.0000 | 0 | 9999.99% | 0.00% |
| June 12, 2024 | Pacira BioSciences, Inc. | $PCRX | HASTINGS PAUL J | Director | A | Common Stock | 5230 | $0.00 | 13,604.0000 | 51,979,000 | 62.46% | 0.01% |
| June 13, 2024 | Pacira BioSciences, Inc. | $PCRX | HASTINGS PAUL J | Director | S | Common Stock | 880 | $28.38 | 12,724.0000 | 51,979,000 | 6.47% | 0.00% |
| June 12, 2024 | Pacira BioSciences, Inc. | $PCRX | HASTINGS PAUL J | Director | A | Stock Option (Right to Buy) | 12179 | $0.00 | 12,179.0000 | 51,979,000 | 9999.99% | 0.02% |
| March 4, 2024 | Nkarta, Inc. | $NKTX | HASTINGS PAUL J | Chief Executive Officer | D | Common Stock | 137642 | $13.33 | 240,507.0000 | 49,014,300 | 36.40% | 0.28% |
| March 1, 2024 | Nkarta, Inc. | $NKTX | HASTINGS PAUL J | Chief Executive Officer | D | Common Stock | 12358 | $13.00 | 378,149.0000 | 49,014,300 | 3.16% | 0.03% |
| Jan. 16, 2024 | Nkarta, Inc. | $NKTX | HASTINGS PAUL J | Chief Executive Officer | S | Common Stock | 9697 | $8.74 | 390,507.0000 | 49,014,300 | 2.42% | 0.02% |
| Jan. 4, 2024 | Nkarta, Inc. | $NKTX | HASTINGS PAUL J | Chief Executive Officer | A | Common Stock | 85000 | $0.00 | 400,204.0000 | 49,014,300 | 26.97% | 0.17% |
| Jan. 4, 2024 | Nkarta, Inc. | $NKTX | HASTINGS PAUL J | Chief Executive Officer | A | Stock Option (right to buy) | 509500 | $0.00 | 509,500.0000 | 49,014,300 | 9999.99% | 1.04% |
| June 14, 2023 | Pacira BioSciences, Inc. | $PCRX | HASTINGS PAUL J | Director | A | Stock Option (Right to Buy) | 12925 | $0.00 | 12,925.0000 | 46,538,000 | 9999.99% | 0.03% |
| June 14, 2023 | Pacira BioSciences, Inc. | $PCRX | HASTINGS PAUL J | Director | A | Common Stock | 1775 | $0.00 | 8,374.0000 | 46,538,000 | 26.90% | 0.00% |
| June 5, 2023 | Pacira BioSciences, Inc. | $PCRX | HASTINGS PAUL J | Director | S | Common Stock | 580 | $38.34 | 6,599.0000 | 46,538,000 | 8.08% | 0.00% |
| May 15, 2023 | Pacira BioSciences, Inc. | $PCRX | HASTINGS PAUL J | Director | M | Common Stock | 7000 | $29.90 | 14,179.0000 | 46,538,000 | 97.51% | 0.02% |
| May 15, 2023 | Pacira BioSciences, Inc. | $PCRX | HASTINGS PAUL J | Director | S | Common Stock | 7000 | $41.85 | 7,179.0000 | 46,538,000 | 49.37% | 0.02% |
| May 15, 2023 | Pacira BioSciences, Inc. | $PCRX | HASTINGS PAUL J | Director | M | Stock Option (Right to Buy) | 7000 | $0.00 | 0.0000 | 46,538,000 | 100.00% | 0.02% |